Nebivolol or Metoprolol in Arterial Occlusive Disease: A double-blind, randomised controlled trial.

Trial Profile

Nebivolol or Metoprolol in Arterial Occlusive Disease: A double-blind, randomised controlled trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2011

At a glance

  • Drugs Metoprolol; Nebivolol
  • Indications Essential hypertension; Peripheral arterial occlusive disorders
  • Focus Pharmacodynamics
  • Acronyms NORMA
  • Sponsors Berlin Chemie
  • Most Recent Events

    • 06 Jun 2011 Results published in the Hypertension.
    • 06 Jun 2011 Status changed from recruiting to completed.
    • 25 Jun 2010 Planned end date (1 Apr 2010) added as reported by ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top